This observation suggests the possibility of common higher-order mechanisms of increased HSF1 and HSP gene expression in such cancers, including permissive chromatin rearrangements, copy number variation (e.g., ovarian cancer, Figure 2 and Figure 4), or common regulators, such as the discussed NOTCH1 [47]. The gene discussed is HSP90B2P; the disease is cancer.